Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06279689 · ClinicalTrials.gov registry record · NA
Echography Study_Anthropometric Measurements
A NA study of Healthy Subjects, sponsored by Crossject.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06279689: Recruiting NA study of Healthy Subjects, sponsored by Crossject.
NCT06279689 is a NA study of Healthy Subjects that is actively recruiting participants, run by Crossject. The registered enrollment target is 90 participants, below the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06279689, a NA study of Healthy Subjects, is actively recruiting participants, sponsored by Crossject.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multi-center, exploratory, estimation study in both adult and pediatric populations. There is no investigational product injection during this study The exploratory objective of this study is to evaluate the anatomical characteristics of both anterolateral thighs in healthy adult and healthy pediatric populations (2 to 17 years old) by ultrasound scan before and while applying a force similar to the ZENEO® triggering force. In the healthy adult population, anatomical characteristics of one shoulder (deltoid) and one upper arm (biceps and triceps) will also be evaluated by ultrasound scan before and while applying a force similar to ZENEO® triggering force. Only ultrasound procedures will be performed using an investigational ultrasound system. All subjects will be asked to undergo 1 on site visit (Study Visit) during which the eligibility assessment and the ultrasound scans will be performed.
Conditions Studied
Interventions
- OTHER Ultrasound scans
Study Locations (1)
Texas
- Clinical Trials of Texas, LLC dba Flourish Research - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-02-13 |
| Est. Completion | 2024-09 |
| Phase | NA |
What NCT06279689 shows while recruiting
NCT06279689 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound scans is the first listed.
NCT06279689 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06279689 about?
NCT06279689 is a clinical study titled "Echography Study_Anthropometric Measurements". This is a multi-center, exploratory, estimation study in both adult and pediatric populations. There is no investigational product injection during this study The exploratory objective of this study is to evaluate the anatomical characteristics of both anterolateral thighs in healthy adult and healt...
What is the current status of trial NCT06279689?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-02-13. Estimated completion is 2024-09.
What conditions does trial NCT06279689 study?
This clinical trial studies the following conditions: Healthy Subjects.
What interventions are being tested in trial NCT06279689?
The interventions under investigation include: Ultrasound scans (OTHER).
Who is sponsoring clinical trial NCT06279689?
This trial is sponsored by Crossject, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06279689 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06279689's enrollment target sits among peer trials
90 14th of 69 higher than 55 of 69 other Healthy Subjects trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Subjects trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Ultrasound-induced Anti-inflammation in Human Subjects
RECRUITING · NA
-
The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
RECRUITING · NA
-
Avocado and Postprandial Responses
RECRUITING · NA
-
Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter
RECRUITING · NA
-
In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
RECRUITING · NA
-
Cerebral Cortical Influences on Autonomic Function
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI